MSP Recovery, Inc. Files 8-K on Delisting Concerns

Ticker: MSPRZ · Form: 8-K · Filed: Dec 4, 2025 · CIK: 1802450

Msp Recovery, INC. 8-K Filing Summary
FieldDetail
CompanyMsp Recovery, INC. (MSPRZ)
Form Type8-K
Filed DateDec 4, 2025
Risk Levelhigh
Pages4
Reading Time5 min
Key Dollar Amounts$0.0001, $50,312.50, $0.4375, $2.5 m, $35 million
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, financial-statements

Related Tickers: MSPR

TL;DR

MSP Recovery (MSPR) facing delisting issues, filed 8-K with financials.

AI Summary

On November 28, 2025, MSP Recovery, Inc. filed an 8-K report detailing a notice of delisting or failure to satisfy a continued listing rule or standard, and also included financial statements and exhibits. The company, formerly known as Lionheart Acquisition Corp. II and Lionheart Acquisition Corp., is based in Miami, Florida.

Why It Matters

This filing indicates potential issues with MSP Recovery, Inc.'s continued listing on an exchange, which could impact its stock price and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a significant red flag for a company's financial health and operational stability.

Key Players & Entities

FAQ

What specific listing rule or standard has MSP Recovery, Inc. failed to satisfy?

The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on November 28, 2025.

What were MSP Recovery, Inc.'s previous names?

MSP Recovery, Inc. was formerly known as Lionheart Acquisition Corp. II and Lionheart Acquisition Corp.

What is the business address of MSP Recovery, Inc.?

The business address is 3150 SW 38TH AVENUE, SUITE 1100, MIAMI, FL 33146.

What type of report is this filing?

This filing is a Form 8-K, a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 1,157 words · 5 min read · ~4 pages · Grade level 16.1 · Accepted 2025-12-04 16:30:25

Key Financial Figures

Filing Documents

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on October 22, 2025, the Company received a Staff Delisting Determination (the "Delisting Notification"), notifying the Company that it was not in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), as the Company's stockholders' equity reported in the Company's Form 10-K for the year ended December 31, 2024, was below the required minimum of $2.5 million, and the Company did not meet the alternative compliance standards, relating to the market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years. On October 29, 2025 the Company timely requested a review of the Delisting Notification by a Hearings Panel (the "Panel"), and on November 21, 2025, the Company timely submitted its Required Written Submission to the Panel. The hearing request has stayed suspension of trading of the Company's securities and the filing of the Form 25-NSE, pending the Panel's decision. The Panel will conduct its hearing on December 11, 2025. On November 28, 2025, the Company received an additional staff determination letter ("Additional Staff Determination") indicating that the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, the Company is not in compliance with Listing Rule 5550(a)(2). The Staff determined that such non-compliance served as an additional basis for delisting the Company's securities from Nasdaq. The Company will be afforded an opportunity to present its views to the Panel with respect to this additional deficiency at the December 11, 2025 hearing. There can be no assurance that the Panel will grant

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MSP R ECOVERY , I NC . Dated: December 4, 2025 By: /s/ Francisco Rivas-Vasquez Name: Francisco Rivas-Vasquez Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing